India’s pharmaceutical exports are poised for powerful growth by 2026, with Hyderabad emerging as a critical hub in this surge. The city, often dubbed the “Genome Valley,” is home to numerous biotechnology and pharmaceutical companies, contributing significantly to the nation’s export landscape. The Indian pharmaceutical industry is anticipated to grow exponentially due to rising global demand for affordable medicines, particularly in developing nations.
Hyderabad’s strategic location and advanced infrastructure facilitate efficient manufacturing and distribution. The focus on research and development, supported by government initiatives, fosters innovation in drug development and production, boosting competitiveness in international markets. Additionally, the city’s skilled workforce is instrumental in maintaining high-quality standards.
As India aims to increase its share in the global pharmaceutical market, Hyderabad is expected to play a pivotal role in fulfilling this vision. With ongoing investments and collaborations, the city is set to solidify its position as a leader in pharmaceuticals, supporting India’s overarching growth objectives in the sector.
For more details and the full reference, visit the source link below:
Read the complete article here: https://parliamentnews.co.uk/pharma-exports-india-2026-hyderabad
